The Voyage Study is evaluating the safety and efficacy of an investigational drug for severe asthma in children 6 to 11 years of age.
Who may qualify.
This study is open to those who meet the following criteria (among other qualifiers):
- Are 6 to 11 years of age
- Have a doctor’s diagnosis of severe asthma for at least one year prior to screening
Have experienced either of the following within one year prior to the start of the study:
- Treatment (at least once) with a systemic steroid (oral or parenteral) for worsening asthma
- Hospitalization or emergency medical care visit for worsening asthma
See If Your Child May Qualify
Learn more about living with severe asthma.